- call +1-201-465-4211
- email sales@mrinsights.biz
Companion Animal Specialty Drug is a kind of veterinary drugs that pet owners used to treatment and care of animals.
Scope of the Report:
This report studies the Companion Animal Specialty Drugs market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Companion Animal Specialty Drugs market by product type and applications/end industries.
The Americas has the presence of large veterinary markets such as the US and Canada. The companion animal specialty drugs market is witnessing continuous growth in the region due to the rising awareness and the availability of companion animal healthcare. Furthermore, the increase in disposable incomes of pet owners and economic development, will also contribute to the growth of the market in this region.
The global Companion Animal Specialty Drugs market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Companion Animal Specialty Drugs.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Bayer
Elanco
Merial
Zoetis
Aratana therapeutics
Beaphar
Henry Schein
Mars
The J.M Smucker Company
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Vaccines
Antibiotics
Parasiticides
Feed Additives
Other
Market Segment by Applications, can be divided into
Veterinary Hospitals
Pet Care Clinics
Pharmacy Stores
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Companion Animal Specialty Drugs Market Overview
1.1 Product Overview and Scope of Companion Animal Specialty Drugs
1.2 Classification of Companion Animal Specialty Drugs by Types
1.2.1 Global Companion Animal Specialty Drugs Revenue Comparison by Types (2017-2023)
1.2.2 Global Companion Animal Specialty Drugs Revenue Market Share by Types in 2017
1.2.3 Vaccines
1.2.4 Antibiotics
1.2.5 Parasiticides
1.2.6 Feed Additives
1.2.7 Other
1.3 Global Companion Animal Specialty Drugs Market by Application
1.3.1 Global Companion Animal Specialty Drugs Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Veterinary Hospitals
1.3.3 Pet Care Clinics
1.3.4 Pharmacy Stores
1.4 Global Companion Animal Specialty Drugs Market by Regions
1.4.1 Global Companion Animal Specialty Drugs Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Companion Animal Specialty Drugs Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Companion Animal Specialty Drugs Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Companion Animal Specialty Drugs Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Companion Animal Specialty Drugs Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Companion Animal Specialty Drugs Status and Prospect (2013-2023)
1.5 Global Market Size of Companion Animal Specialty Drugs (2013-2023)
2 Manufacturers Profiles
2.1 Bayer
2.1.1 Business Overview
2.1.2 Companion Animal Specialty Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Bayer Companion Animal Specialty Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.2 Elanco
2.2.1 Business Overview
2.2.2 Companion Animal Specialty Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Elanco Companion Animal Specialty Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.3 Merial
2.3.1 Business Overview
2.3.2 Companion Animal Specialty Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Merial Companion Animal Specialty Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.4 Zoetis
2.4.1 Business Overview
2.4.2 Companion Animal Specialty Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Zoetis Companion Animal Specialty Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.5 Aratana therapeutics
2.5.1 Business Overview
2.5.2 Companion Animal Specialty Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Aratana therapeutics Companion Animal Specialty Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.6 Beaphar
2.6.1 Business Overview
2.6.2 Companion Animal Specialty Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Beaphar Companion Animal Specialty Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.7 Henry Schein
2.7.1 Business Overview
2.7.2 Companion Animal Specialty Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Henry Schein Companion Animal Specialty Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.8 Mars
2.8.1 Business Overview
2.8.2 Companion Animal Specialty Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Mars Companion Animal Specialty Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.9 The J.M Smucker Company
2.9.1 Business Overview
2.9.2 Companion Animal Specialty Drugs Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 The J.M Smucker Company Companion Animal Specialty Drugs Revenue, Gross Margin and Market Share (2016-2017)
3 Global Companion Animal Specialty Drugs Market Competition, by Players
3.1 Global Companion Animal Specialty Drugs Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Companion Animal Specialty Drugs Players Market Share
3.2.2 Top 10 Companion Animal Specialty Drugs Players Market Share
3.3 Market Competition Trend
4 Global Companion Animal Specialty Drugs Market Size by Regions
4.1 Global Companion Animal Specialty Drugs Revenue and Market Share by Regions
4.2 North America Companion Animal Specialty Drugs Revenue and Growth Rate (2013-2018)
4.3 Europe Companion Animal Specialty Drugs Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Companion Animal Specialty Drugs Revenue and Growth Rate (2013-2018)
4.5 South America Companion Animal Specialty Drugs Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Companion Animal Specialty Drugs Revenue and Growth Rate (2013-2018)
5 North America Companion Animal Specialty Drugs Revenue by Countries
5.1 North America Companion Animal Specialty Drugs Revenue by Countries (2013-2018)
5.2 USA Companion Animal Specialty Drugs Revenue and Growth Rate (2013-2018)
5.3 Canada Companion Animal Specialty Drugs Revenue and Growth Rate (2013-2018)
5.4 Mexico Companion Animal Specialty Drugs Revenue and Growth Rate (2013-2018)
6 Europe Companion Animal Specialty Drugs Revenue by Countries
6.1 Europe Companion Animal Specialty Drugs Revenue by Countries (2013-2018)
6.2 Germany Companion Animal Specialty Drugs Revenue and Growth Rate (2013-2018)
6.3 UK Companion Animal Specialty Drugs Revenue and Growth Rate (2013-2018)
6.4 France Companion Animal Specialty Drugs Revenue and Growth Rate (2013-2018)
6.5 Russia Companion Animal Specialty Drugs Revenue and Growth Rate (2013-2018)
6.6 Italy Companion Animal Specialty Drugs Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Companion Animal Specialty Drugs Revenue by Countries
7.1 Asia-Pacific Companion Animal Specialty Drugs Revenue by Countries (2013-2018)
7.2 China Companion Animal Specialty Drugs Revenue and Growth Rate (2013-2018)
7.3 Japan Companion Animal Specialty Drugs Revenue and Growth Rate (2013-2018)
7.4 Korea Companion Animal Specialty Drugs Revenue and Growth Rate (2013-2018)
7.5 India Companion Animal Specialty Drugs Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Companion Animal Specialty Drugs Revenue and Growth Rate (2013-2018)
8 South America Companion Animal Specialty Drugs Revenue by Countries
8.1 South America Companion Animal Specialty Drugs Revenue by Countries (2013-2018)
8.2 Brazil Companion Animal Specialty Drugs Revenue and Growth Rate (2013-2018)
8.3 Argentina Companion Animal Specialty Drugs Revenue and Growth Rate (2013-2018)
8.4 Colombia Companion Animal Specialty Drugs Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Companion Animal Specialty Drugs by Countries
9.1 Middle East and Africa Companion Animal Specialty Drugs Revenue by Countries (2013-2018)
9.2 Saudi Arabia Companion Animal Specialty Drugs Revenue and Growth Rate (2013-2018)
9.3 UAE Companion Animal Specialty Drugs Revenue and Growth Rate (2013-2018)
9.4 Egypt Companion Animal Specialty Drugs Revenue and Growth Rate (2013-2018)
9.5 Nigeria Companion Animal Specialty Drugs Revenue and Growth Rate (2013-2018)
9.6 South Africa Companion Animal Specialty Drugs Revenue and Growth Rate (2013-2018)
10 Global Companion Animal Specialty Drugs Market Segment by Type
10.1 Global Companion Animal Specialty Drugs Revenue and Market Share by Type (2013-2018)
10.2 Global Companion Animal Specialty Drugs Market Forecast by Type (2018-2023)
10.3 Vaccines Revenue Growth Rate (2013-2023)
10.4 Antibiotics Revenue Growth Rate (2013-2023)
10.5 Parasiticides Revenue Growth Rate (2013-2023)
10.6 Feed Additives Revenue Growth Rate (2013-2023)
10.7 Other Revenue Growth Rate (2013-2023)
11 Global Companion Animal Specialty Drugs Market Segment by Application
11.1 Global Companion Animal Specialty Drugs Revenue Market Share by Application (2013-2018)
11.2 Companion Animal Specialty Drugs Market Forecast by Application (2018-2023)
11.3 Veterinary Hospitals Revenue Growth (2013-2018)
11.4 Pet Care Clinics Revenue Growth (2013-2018)
11.5 Pharmacy Stores Revenue Growth (2013-2018)
12 Global Companion Animal Specialty Drugs Market Size Forecast (2018-2023)
12.1 Global Companion Animal Specialty Drugs Market Size Forecast (2018-2023)
12.2 Global Companion Animal Specialty Drugs Market Forecast by Regions (2018-2023)
12.3 North America Companion Animal Specialty Drugs Revenue Market Forecast (2018-2023)
12.4 Europe Companion Animal Specialty Drugs Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Companion Animal Specialty Drugs Revenue Market Forecast (2018-2023)
12.6 South America Companion Animal Specialty Drugs Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Companion Animal Specialty Drugs Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Companion Animal Specialty Drugs Picture
Table Product Specifications of Companion Animal Specialty Drugs
Table Global Companion Animal Specialty Drugs and Revenue (
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
